Sickle cell disease (SCD) is a chronic multisystem disorder associated with vaso-occlusive pain and organ damage, leading to substantial morbidity, impaired health-related quality of life, substantial health care costs, and a high risk of premature mortality.
1 Acute, episodic vaso-occlusive pain may progress to chronic persistent pain
2 in more than a third of adults with SCD.
2 Opioid analgesics are the mainstay for the management of acute and chronic pain in SCD.
2